人类癌症增殖和转移中的一种新型调节因子。
: a novel regulator in human cancer proliferation and metastasis.
作者信息
Xue Jiang-Yang, Huang Chao, Wang Wei, Li Hai-Bo, Sun Ming, Xie Min
机构信息
Center for Reproduction and Genetics, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, China.
Central Laboratory, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, China,
出版信息
Onco Targets Ther. 2018 Jul 27;11:4387-4393. doi: 10.2147/OTT.S166961. eCollection 2018.
Abstract
Multiple studies have demonstrated that lncRNAs extensively participate in human cancer proliferation and metastasis. Epigenetic modification, transcriptional and posttranscriptional regulatory mechanisms are involved in lncRNA-led tumorigenesis and transfer. Recently, a novel identified homeobox (HOX) A11 antisense lncRNA, , 1,628 bp in length, has been excessively highlighted to be an essential initiator and facilitator in the process of malignant tumor proliferation and metastasis. As found in many reports, can not only act as a molecular scaffold of PRC2, LSD1 and DNMT1 to epigenetically modify chromosomes in the nucleus but also occur as ceRNA competitively sponging miRNAs in the cytoplasm. Furthermore, may function as a potential biomarker for cancer diagnosis and prognosis. In this review, we summarize the evolvement and mechanisms of in proliferation and metastasis of various human cancers.
摘要
多项研究表明，长链非编码RNA（lncRNAs）广泛参与人类癌症的增殖和转移。表观遗传修饰、转录及转录后调控机制均涉及lncRNA介导的肿瘤发生和转移。最近，一种新鉴定出的长度为1628 bp的同源盒（HOX）A11反义lncRNA，在恶性肿瘤增殖和转移过程中被过度强调为重要的启动子和促进因子。正如许多报道中所发现的，它不仅可以作为多梳蛋白2（PRC2）、赖氨酸特异性去甲基化酶1（LSD1）和DNA甲基转移酶1（DNMT1）的分子支架，在细胞核中对染色体进行表观遗传修饰，还可以作为竞争性内源RNA（ceRNA）在细胞质中竞争性结合微小RNA（miRNAs）。此外，它可能作为癌症诊断和预后的潜在生物标志物。在本综述中，我们总结了其在各种人类癌症增殖和转移中的演变及机制。
相似文献
1
: a novel regulator in human cancer proliferation and metastasis.人类癌症增殖和转移中的一种新型调节因子。
Onco Targets Ther. 2018 Jul 27;11:4387-4393. doi: 10.2147/OTT.S166961. eCollection 2018.
2
Recent advances in unraveling the molecular mechanisms and functions of HOXA11‑AS in human cancers and other diseases (Review).揭示 HOXA11-AS 在人类癌症和其他疾病中的分子机制和功能的最新进展（综述）。
Oncol Rep. 2020 Jun;43(6):1737-1754. doi: 10.3892/or.2020.7552. Epub 2020 Mar 19.
3
LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1.长链非编码 RNA HOXA11-AS 通过支架染色质修饰因子 PRC2、 LSD1 和 DNMT1 促进胃癌的增殖和侵袭。
Cancer Res. 2016 Nov 1;76(21):6299-6310. doi: 10.1158/0008-5472.CAN-16-0356. Epub 2016 Sep 20.
4
The lncRNA HOXA11-AS functions as a competing endogenous RNA to regulate PADI2 expression by sponging miR-125a-5p in liver metastasis of colorectal cancer.长链非编码RNA HOXA11-AS作为一种竞争性内源性RNA，通过吸附miR-125a-5p来调节结直肠癌肝转移中PADI2的表达。
Oncotarget. 2017 Aug 3;8(41):70642-70652. doi: 10.18632/oncotarget.19956. eCollection 2017 Sep 19.
5
Long non-coding RNA homeobox A11 antisense RNA (HOXA11-AS) promotes retinoblastoma progression via sponging miR-506-3p.长链非编码RNA同源盒A11反义RNA（HOXA11-AS）通过海绵吸附miR-506-3p促进视网膜母细胞瘤进展。
Onco Targets Ther. 2019 May 7;12:3509-3517. doi: 10.2147/OTT.S195404. eCollection 2019.
6
Over-expressed long noncoding RNA HOXA11-AS promotes cell cycle progression and metastasis in gastric cancer.过表达的长链非编码RNA HOXA11-AS促进胃癌细胞周期进程和转移。
Mol Cancer. 2017 Apr 26;16(1):82. doi: 10.1186/s12943-017-0651-6.
7
Overexpression of lncRNA HOXA11-AS promotes cell epithelial-mesenchymal transition by repressing miR-200b in non-small cell lung cancer.lncRNA HOXA11-AS的过表达通过抑制非小细胞肺癌中的miR-200b促进细胞上皮-间质转化。
Cancer Cell Int. 2017 Jun 12;17:64. doi: 10.1186/s12935-017-0433-7. eCollection 2017.
8
HOXA11-AS promotes the growth and invasion of renal cancer by sponging miR-146b-5p to upregulate MMP16 expression.HOXA11-AS 通过海绵吸附 miR-146b-5p 来上调 MMP16 表达，促进肾癌细胞的生长和侵袭。
J Cell Physiol. 2018 Dec;233(12):9611-9619. doi: 10.1002/jcp.26864. Epub 2018 Jun 28.
9
Long non-coding RNA homeobox (HOX) A11-AS promotes malignant progression of glioma by targeting miR-124-3p.长链非编码 RNA 同源盒（HOX）A11-AS 通过靶向 miR-124-3p 促进胶质瘤的恶性进展。
Neoplasma. 2018;65(4):505-514. doi: 10.4149/neo_2018_170705N462.
10
Long non-coding RNA HOXA11-AS in human cancer: A meta-analysis.长链非编码 RNA HOXA11-AS 在人类癌症中的作用：一项荟萃分析。
Clin Chim Acta. 2017 Nov;474:165-170. doi: 10.1016/j.cca.2017.09.015. Epub 2017 Sep 21.
引用本文的文献
1
Abnormal methylation of HOXA11 promoter promotes tumor progression in testicular germ cell tumor.HOXA11基因启动子的异常甲基化促进睾丸生殖细胞肿瘤的肿瘤进展。
Am J Transl Res. 2024 May 15;16(5):1660-1668. doi: 10.62347/HJKI7733. eCollection 2024.
2
Long non-coding RNA HOXA11-AS regulates ischemic neuronal death by targeting miR-337-3p/YBX1 signaling pathway: protective effect of dexmedetomidine.长链非编码 RNA HOXA11-AS 通过靶向 miR-337-3p/YBX1 信号通路调节缺血性神经元死亡：右美托咪定的保护作用。
Aging (Albany NY). 2023 Apr 10;15(7):2797-2811. doi: 10.18632/aging.204648.
3
Long non-coding RNA HOXA11-AS protects the barrier function of corneal endothelial cells by sponging microRNA-155 to alleviate corneal endothelial injury.长链非编码RNA HOXA11-AS通过吸附微小RNA-155减轻角膜内皮损伤，从而保护角膜内皮细胞的屏障功能。
Am J Transl Res. 2022 Dec 15;14(12):8489-8503. eCollection 2022.
4
HOXA11-OS participates in lupus nephritis by targeting miR-124-3p mediating Cyr61 to regulate podocyte autophagy.HOXA11-OS 通过靶向 miR-124-3p 介导 Cyr61 调控足细胞自噬参与狼疮肾炎。
Mol Med. 2022 Nov 22;28(1):138. doi: 10.1186/s10020-022-00570-w.
5
Long non-coding RNAs involved in retinoblastoma.参与视网膜母细胞瘤的长链非编码RNA
J Cancer Res Clin Oncol. 2023 Jan;149(1):401-421. doi: 10.1007/s00432-022-04398-z. Epub 2022 Oct 28.
6
An Axis between the Long Non-Coding RNA and NQOs Enhances Metastatic Ability in Oral Squamous Cell Carcinoma.长链非编码 RNA 和 NQO 之间的轴增强口腔鳞状细胞癌的转移能力。
Int J Mol Sci. 2022 Sep 14;23(18):10704. doi: 10.3390/ijms231810704.
7
Emerging role of lncRNAs in drug resistance mechanisms in head and neck squamous cell carcinoma.长链非编码RNA在头颈部鳞状细胞癌耐药机制中的新作用
Front Oncol. 2022 Aug 1;12:965628. doi: 10.3389/fonc.2022.965628. eCollection 2022.
8
Solamargine Inhibits the Development of Hypopharyngeal Squamous Cell Carcinoma by Decreasing LncRNA Expression.澳洲茄碱通过降低长链非编码RNA的表达抑制下咽鳞状细胞癌的发展。
Front Pharmacol. 2022 Jul 12;13:887387. doi: 10.3389/fphar.2022.887387. eCollection 2022.
9
Long non-coding RNA HOXA11-AS knockout inhibits proliferation and overcomes drug resistance in ovarian cancer.长链非编码 RNA HOXA11-AS 敲除抑制卵巢癌细胞增殖并克服耐药性。
Bioengineered. 2022 May;13(5):13893-13905. doi: 10.1080/21655979.2022.2086377.
10
Natural antisense RNA Foxk1-AS promotes myogenic differentiation by inhibiting Foxk1 activity.自然反义 RNA Foxk1-AS 通过抑制 Foxk1 活性促进成肌分化。
Cell Commun Signal. 2022 May 31;20(1):77. doi: 10.1186/s12964-022-00896-2.
本文引用的文献
1
Long non-coding RNA HOXA11-AS promotes the proliferation HCC cells by epigenetically silencing DUSP5.长链非编码RNA HOXA11-AS通过表观遗传沉默DUSP5促进肝癌细胞增殖。
Oncotarget. 2017 Nov 27;8(65):109509-109521. doi: 10.18632/oncotarget.22723. eCollection 2017 Dec 12.
2
Prognostic and clinicopathological significance of long noncoding RNA HOXA11-AS expression in human solid tumors: a meta-analysis.长链非编码RNA HOXA11-AS表达在人类实体瘤中的预后及临床病理意义：一项荟萃分析
Cancer Cell Int. 2018 Jan 3;18:1. doi: 10.1186/s12935-017-0498-3. eCollection 2018.
3
Effect of lncRNA HOXA11-AS1 on adipocyte differentiation in human adipose-derived stem cells.长链非编码RNA HOXA11-AS1对人脂肪来源干细胞中脂肪细胞分化的影响
Biochem Biophys Res Commun. 2018 Jan 8;495(2):1878-1884. doi: 10.1016/j.bbrc.2017.12.006. Epub 2017 Dec 5.
4
lncRNA HOXA11-AS is involved in fracture healing through regulating mir-124-3p.长链非编码 RNA HOXA11-AS 通过调节 mir-124-3p 参与骨折愈合。
Eur Rev Med Pharmacol Sci. 2017 Nov;21(21):4771-4776.
5
Social integration and survival after diagnosis of colorectal cancer.结直肠癌诊断后的社会融合与生存。
Cancer. 2018 Feb 15;124(4):833-840. doi: 10.1002/cncr.31117. Epub 2017 Nov 21.
6
Palbociclib-Induced Thrombotic Microangiopathy in Metastatic Breast Cancer Patient Surviving for 18 Years: Case Report and Review of the Literature.帕博西尼诱发转移性乳腺癌患者血栓性微血管病并存活18年：病例报告及文献综述
Clin Breast Cancer. 2018 Jun;18(3):e263-e266. doi: 10.1016/j.clbc.2017.10.001. Epub 2017 Oct 7.
7
Organelle Specific O-Glycosylation Drives MMP14 Activation, Tumor Growth, and Metastasis.细胞器特异性 O-糖基化驱动 MMP14 激活、肿瘤生长和转移。
Cancer Cell. 2017 Nov 13;32(5):639-653.e6. doi: 10.1016/j.ccell.2017.10.001.
8
Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer.长链非编码 RNA NORAD，一种新型的竞争性内源性 RNA，增强了缺氧诱导的上皮-间充质转化，促进了胰腺癌的转移。
Mol Cancer. 2017 Nov 9;16(1):169. doi: 10.1186/s12943-017-0738-0.
9
Profiling, clinicopathological correlation and functional validation of specific long non-coding RNAs for hepatocellular carcinoma.特定长非编码 RNA 用于肝癌的分析、临床病理相关性和功能验证。
Mol Cancer. 2017 Oct 23;16(1):164. doi: 10.1186/s12943-017-0733-5.
10
The lncRNA HOXA11-AS functions as a competing endogenous RNA to regulate PADI2 expression by sponging miR-125a-5p in liver metastasis of colorectal cancer.长链非编码RNA HOXA11-AS作为一种竞争性内源性RNA，通过吸附miR-125a-5p来调节结直肠癌肝转移中PADI2的表达。
Oncotarget. 2017 Aug 3;8(41):70642-70652. doi: 10.18632/oncotarget.19956. eCollection 2017 Sep 19.
Zotero 插件